Cardiff Oncology, Inc. (CRDF)
NASDAQ:CRDF
Holding CRDF?
Track your performance easily

Cardiff Oncology (CRDF) Financial Statements

1,505 Followers

Cardiff Oncology Financial Overview

Cardiff Oncology's market cap is currently ―. The company's EPS TTM is $-0.914; its P/E ratio is -3.51; Cardiff Oncology is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 163.00K$ 205.00K$ 156.00K$ 141.00K$ 108.00K
Gross Profit$ 163.00K$ 205.00K$ 156.00K$ 141.00K$ 108.00K
EBIT$ -11.78M$ -10.93M$ -10.33M$ -9.73M$ -11.15M
EBITDA$ -11.52M$ -10.83M$ -10.23M$ -9.94M$ -11.29M
Net Income Common Stockholders$ -11.78M$ -10.02M$ -9.34M$ -9.74M$ -11.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 60.32M$ 67.19M$ 74.82M$ 81.36M$ 89.43M
Total Assets$ 66.05M$ 74.04M$ 81.64M$ 88.45M$ 97.45M
Total Debt$ 1.84M$ 2.00M$ 2.15M$ 2.29M$ 2.44M
Net Debt$ -58.48M$ -65.19M$ -72.67M$ -79.07M$ -86.99M
Total Liabilities$ 13.66M$ 13.14M$ 11.90M$ 10.63M$ 10.88M
Stockholders Equity$ 52.39M$ 60.89M$ 69.74M$ 77.83M$ 86.58M
Cash Flow-
Free Cash Flow$ -9.23M$ -7.82M$ -7.15M$ -8.27M$ -7.38M
Operating Cash Flow$ -9.23M$ -7.74M$ -7.14M$ -7.96M$ -7.13M
Investing Cash Flow$ 14.02M$ 4.64M$ 13.56M$ 3.82M$ 11.48M
Financing Cash Flow$ 2.06M$ 107.00K---
Currency in USD

Cardiff Oncology Earnings and Revenue History

Cardiff Oncology Debt to Assets

Cardiff Oncology Cash Flow

Cardiff Oncology Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis